Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM97447![]() (Aspartyl protease inhibitor, 13) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | 5.5 | n/a |
Philipps-Universität Marburg | Assay Description Binding constants for inhibition of HIV protease were determined as previously described. | ChemMedChem 1: 106-17 (2006) Article DOI: 10.1002/cmdc.200500008 BindingDB Entry DOI: 10.7270/Q228067M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM97448![]() (Aspartyl protease inhibitor, 14) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 3.30E+3 | n/a | n/a | n/a | n/a | 5.5 | n/a |
Philipps-Universität Marburg | Assay Description Binding constants for inhibition of HIV protease were determined as previously described. | ChemMedChem 1: 106-17 (2006) Article DOI: 10.1002/cmdc.200500008 BindingDB Entry DOI: 10.7270/Q228067M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM97451![]() (Aspartyl protease inhibitor, 17) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.21E+4 | n/a | n/a | n/a | n/a | 5.5 | n/a |
Philipps-Universität Marburg | Assay Description Binding constants for inhibition of HIV protease were determined as previously described. | ChemMedChem 1: 106-17 (2006) Article DOI: 10.1002/cmdc.200500008 BindingDB Entry DOI: 10.7270/Q228067M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM97450![]() (Aspartyl protease inhibitor, 16) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.98E+4 | n/a | n/a | n/a | n/a | 5.5 | n/a |
Philipps-Universität Marburg | Assay Description Binding constants for inhibition of HIV protease were determined as previously described. | ChemMedChem 1: 106-17 (2006) Article DOI: 10.1002/cmdc.200500008 BindingDB Entry DOI: 10.7270/Q228067M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM97449![]() (Aspartyl protease inhibitor, 15) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.21E+4 | n/a | n/a | n/a | n/a | 5.5 | n/a |
Philipps-Universität Marburg | Assay Description Binding constants for inhibition of HIV protease were determined as previously described. | ChemMedChem 1: 106-17 (2006) Article DOI: 10.1002/cmdc.200500008 BindingDB Entry DOI: 10.7270/Q228067M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126648![]() (US8785638, 132) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 4.47E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126649![]() (US8785638, 133) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 7.80E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126650![]() (US8785638, 134) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 8.41E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126651![]() (US8785638, 135) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 5.58E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126652![]() (US8785638, 136) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 4.34E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126653![]() (US8785638, 137) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 5.19E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126654![]() (US8785638, 138) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 3.99E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126655![]() (US8785638, 139) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 9.24E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126656![]() (US8785638, 140) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 1.81E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126657![]() (US8785638, 141) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 2.37E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126631![]() (US8785638, 113 | US8785638, 142) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 7.43E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126659![]() (US8785638, 143) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 4.92E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126660![]() (US8785638, 144) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 6.64E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126661![]() (US8785638, 145) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 2.96E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126662![]() (US8785638, 146) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 4.76E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126663![]() (US8785638, 147) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 2.37E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126664![]() (US8785638, 148) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 2.19E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126665![]() (US8785638, 149) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 7.44E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126666![]() (US8785638, 150) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 1.37E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126667![]() (US8785638, 151) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 2.15E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126668![]() (US8785638, 153) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 4.37E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126669![]() (US8785638, 154) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 8.12E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126670![]() (US8785638, 155) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 8.19E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126671![]() (US8785638, 156) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 5.96E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126672![]() (US8785638, 157) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 2.64E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126673![]() (US8785638, 158) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 1.35E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126674![]() (US8785638, 159) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 1.33E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126675![]() (US8785638, 160) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 1.77E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126676![]() (US8785638, 161) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 55.4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126677![]() (US8785638, 162) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 1.57E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126678![]() (US8785638, 163) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126679![]() (US8785638, 165) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126680![]() (US8785638, 166) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126681![]() (US8785638, 167) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 6.37E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126682![]() (US8785638, 170) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 50 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126683![]() (US8785638, 171) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 1.21E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126684![]() (US8785638, 173) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 5.90E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126685![]() (US8785638, 175) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126686![]() (US8785638, 177) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 1.17E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126687![]() (US8785638, 181) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 8.06E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126688![]() (US8785638, 182) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126689![]() (US8785638, 184) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 3.44E+3 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126690![]() (US8785638, 186) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 430 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126691![]() (US8785638, 188) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | n/a | n/a | 1.37E+4 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protease (Human immunodeficiency virus type 1 (HIV-1)) | BDBM126692![]() (US8785638, 190) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | n/a | n/a | 370 | n/a | n/a | n/a | n/a | 7.4 | 4 | |
Katholieke Universiteit Leuven US Patent | Assay Description The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ... | US Patent US8785638 (2014) BindingDB Entry DOI: 10.7270/Q2S18167 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 1117 total ) | Next | Last >> |